Salubris

Salubris is one of the...

• CSI 500.

Salubris is a company listed under the stock ticker 002294 (CN).

View the org chart displaying its 8 main executives

Most searched biographies at Salubris

• Kevin Ye, Chief Executive Officer and Chairman of the Board
• Ling Yang, Director
• Suying He, Independent Director

Create your alert
to follow the executive moves at Salubris.

Salubris has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Salubris

Social media about Salubris

• Salubris on Wikipedia, Google News & Yahoo Finance
• Salubris on LinkedIn, Twitter & YouTube

Call Salubris at +86 75...

View the org chart

Register to receive your alert

Report an error